Codes / ICD10CM / F18.12

F18.12 Inhalant abuse with intoxication

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common Name: Inhalant Abuse with Intoxication
  • Medical Term: Inhalant Abuse with Intoxication

Summary

Inhalant abuse with intoxication refers to the intentional misuse of inhalants—substances that produce chemical vapors—to achieve psychoactive effects, accompanied by acute intoxication. This condition involves the presence of intoxication symptoms during or shortly after inhalant use, which can impair cognitive and physical functioning. Inhalant abuse with intoxication may lead to dependence, organ damage, and other substance-related health issues, affecting an individual's health and daily functioning.

Causes

Inhalant abuse with intoxication is driven by the repeated misuse of inhalants for their psychoactive effects. Inhalants are often everyday household or industrial products, such as glue, paint thinners, aerosols, or solvents. The misuse of these substances can lead to acute intoxication, dependence, and related health issues.

Risk Factors

  • Adolescents and young adults are more likely to experiment with inhalants.
  • Individuals with a history of substance abuse or mental health disorders.
  • Accessibility to inhalant products.
  • Lack of proper supervision or guidance.

Symptoms

  • Intense cravings or compulsive inhalant use.
  • Coordination problems, dizziness, or lethargy.
  • Unexplained behavioral changes such as aggression or mood swings.
  • Cognitive impairment or memory issues.
  • Slurred speech or impaired judgment during intoxication.
  • Nausea, vomiting, or headaches.

Diagnosis

Clinical evaluation including a detailed history of inhalant use, physical examination, and assessment of symptoms. Laboratory tests may be used to detect inhalant exposure or rule out other conditions. Diagnosis requires evidence of recent inhalant use and the presence of intoxication symptoms.

Treatment Options

  • Detoxification to manage withdrawal symptoms.
  • Behavioral therapy to address underlying substance use patterns.
  • Support groups or counseling for long-term recovery.
  • Medications to treat co-occurring mental health conditions.
  • Education on the risks of inhalant misuse.

Prognosis and Follow-Up

Prognosis depends on the severity of use, presence of co-occurring disorders, and adherence to treatment. Regular follow-up is essential to monitor for relapse, manage withdrawal symptoms, and address any ongoing health issues. Long-term recovery may require sustained support and lifestyle changes.

Complications

  • Organ damage (e.g., liver, kidney, or brain).
  • Respiratory failure or cardiac arrest.
  • Neurological impairment or cognitive decline.
  • Increased risk of accidents or injuries.
  • Co-occurring mental health disorders.

Lifestyle & Prevention

  • Avoid exposure to inhalant products.
  • Educate individuals on the risks of inhalant misuse.
  • Provide supervision for at-risk populations (e.g., adolescents).
  • Encourage healthy coping mechanisms and stress management.
  • Seek professional help for substance use concerns.

When to Seek Professional Help

Seek immediate medical attention if experiencing severe symptoms such as difficulty breathing, chest pain, or loss of consciousness. Consult a healthcare provider for persistent inhalant use, withdrawal symptoms, or concerns about substance-related health issues.

Tips for Medical Coders

Document the presence of acute intoxication symptoms and recent inhalant use to support the diagnosis. Ensure clinical notes specify the type of inhalant involved and the duration of intoxication. Verify that the code aligns with the documented clinical findings and meets ICD-10-CM coding guidelines.

Book a walkthrough

F18.12 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.